HALO, UND enter agreement to develop biomarkers for early detection of breast cancer

[News]

HALO Healthcare, Inc., a provider of innovative diagnostic solutions for women's breast care announced that it has signed a definitive license agreement with the University of North Dakota (UND) to develop biomarkers for the early detection of breast cancer.

More... (http://www.news-medical.net/news/20120723/HALO-UND-enter-agreement-to-develop-biomarkers-for-early-detection-of-breast-cancer.aspx)